Business

Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split

CHICAGO, May 08, 2025--Cardio Diagnostics Holdings today announced a 1-for-30 reverse stock split of its common stock effective with the market opening on May 13, 2025.

articleCardio Diagnostics Holdings Inc.May 8, 20254/company/cardio-diagnostics-holdings-inc/news/cardio-diagnostics-holdings-inc-announces-123500099
Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split

About this update from Cardio Diagnostics Holdings Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/9906c9d9cc40af5885759d01f46d0ce3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/cFgvyaCg_xdbacglTtMttQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/9906c9d9cc40af5885759d01f46d0ce3","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/qk5qjC4Kg0.KwmInHLOZ6Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/9906c9d9cc40af5885759d01f46d0ce3","width":1024,"height":512}},"lazy":false},{"type":"text","content":"CHICAGO, May 08, 2025--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. ("Cardio" or the "Company") (NASDAQ: CDIO), today announced a 1-for-30 reverse stock split of its common stock effective with the market opening on May 13, 2025.","length":255,"tagName":"p"},{"type":"text","content":"The reverse stock split will take effect at 11:59 pm Eastern Time on May 12, 2025, and the Company’s common stock will open for trading on The Nasdaq Capital Market on May 13, 2025 on a post-split basis, under the existing ticker symbol "CDIO" but with new CUSIP number 14159C202. The reverse stock split is part of the Company’s plan to regain compliance with the minimum bid price requirement for the continued listing on The Nasdaq Capital Market.","length":460,"tagName":"p"},{"type":"text","content":"The reverse split was authorized by the Company's stockholders on November 15, 2024, granting the Company's Board of Directors (the "Board") the discretion to determine the timing and ratio of the split within a range of 1-5 and 1-40. On April 10, 2025, the Board approved a 1-for-30 reverse stock split (the "Reverse Stock Split") and will amend the Company's Third Amended and Restated Certificate of Incorporation to reflect this action.","length":472,"tagName":"p"},{"type":"text","content":"As a result of the Reverse Stock Split, every 30 shares of the Company’s common stock issued and outstanding prior to the opening of trading on May 13, 2025 will be combined into one issued and outstanding share, with no change in the nominal par value per share of $0.00...

More updates from Cardio Diagnostics Holdings Inc.

reverse stock splitNASDAQThe Companyfractional sharescommon stockauthorized sharesCardio Diagnostics Holdings, Inc.Company